Pierre LEBLOND, MD
Centre Oscar Lambret · IHOP · Centre Oscar Lambret, Lille, France
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Pierre LEBLOND, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:41 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT03585465 · Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid TumorsCentre Oscar Lambret · terminated · Childhood Solid Tumor · study director
- Ph2/Ph3NCT02265770 · An International Clinical Program for the Diagnosis and Treatment of Children With EpendymomaCentre Leon Berard · recruiting · Childhood Ependymoma · principal investigator
- Ph2NCT02197637 · Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade GliomaCentre Oscar Lambret · completed · Low-Grade Glioma · principal investigator
- Ph1NCT02115074 · Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic GliomasCentre Oscar Lambret · completed · Glioma · study director
- Ph1NCT01165333 · Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine GliomaCentre Oscar Lambret · completed · Diffuse Intrinsic Pontine Glioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.